Gemstone Investments Limited reported a net loss of ₹26.80 lakh for the quarter ended December 31, 2025, primarily due to a sharp rise in expenses. The company had recorded a net profit of ₹16.22 lakh in the preceding quarter ended September 30, 2025. Revenue from operations for Q3FY26 stood at ₹58.02 lakh, a significant increase from ₹2.39 lakh in the corresponding quarter of the previous year.

The financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 13, 2026. The Limited Review Report was issued by A. Raghavendra Rao & Associates, Chartered Accountants. The firm noted that nothing came to their attention to suggest the financial statements were not prepared in accordance with applicable accounting standards.

Total expenses for the quarter rose to ₹81.94 lakh, up from ₹13.54 lakh in the same period last year. This increase was driven largely by other expenses, which amounted to ₹62.66 lakh, and a bad debt provision of ₹8.38 lakh. Employee benefits expenses for the quarter were recorded at ₹8.80 lakh. Finance costs also increased to ₹1.63 lakh from ₹0.01 lakh in the preceding quarter.

For the nine months ended December 31, 2025, the company reported a net profit of ₹1.72 lakh, a sharp decline from ₹23.11 lakh in the corresponding period of the previous year. Total revenue for the nine-month period was ₹131.60 lakh, while total expenses aggregated to ₹118.63 lakh. The company’s paid-up equity share capital remained constant at ₹747.50 lakh.

The Board also approved the allotment of convertible equity warrants on a preferential basis. On November 19, 2025, the company allotted 19,98,40,000 warrants, followed by an additional allotment of 19,37,60,000 warrants on November 26, 2025. The company noted that due to the critical illness and hospitalization of the Statutory Auditor, the Limited Review Report was submitted at the earliest possible opportunity.

Financial Performance Summary

Gemstone Investments Limited has announced that its board of directors will meet on Thursday, May 28, 2026, at the company's registered office. The primary agenda of the meeting is to consider and approve the audited standalone financial results for the quarter and fiscal year ended March 31, 2026.

The board will also review the Independent Audit Report to be issued by the statutory auditor, M/s. A. Raghavendra Rao & Associates, Chartered Accountants, for the same period. Other business matters with the permission of the Chairman may also be transacted during the meeting.

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's shares has been closed since April 1, 2026. This closure applies to all directors, promoters, key managerial personnel (KMPs), designated persons, and their immediate relatives. The window will remain shut until the expiry of 48 hours from the declaration of the financial results.

Key Meeting Details